<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3ADiscovery_and_development_of_gliflozins%2F1%2Fen</id>
	<title>Translations:Discovery and development of gliflozins/1/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3ADiscovery_and_development_of_gliflozins%2F1%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Discovery_and_development_of_gliflozins/1/en&amp;action=history"/>
	<updated>2026-07-12T01:07:03Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://wiki.tiffa.net/w/index.php?title=Translations:Discovery_and_development_of_gliflozins/1/en&amp;diff=114387&amp;oldid=prev</id>
		<title>FuzzyBot: Importing a new version from external source</title>
		<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Discovery_and_development_of_gliflozins/1/en&amp;diff=114387&amp;oldid=prev"/>
		<updated>2024-02-14T00:56:19Z</updated>

		<summary type="html">&lt;p&gt;Importing a new version from external source&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[Gliflozin]]s are a class of drugs in the treatment of [[type 2 diabetes]] (T2D). They act by inhibiting [[sodium/glucose cotransporter 2]] (SGLT-2), and are therefore also called SGLT-2 inhibitors. The efficacy of the drug is dependent on renal excretion and prevents [[glucose]] from going into blood circulation by promoting [[glucosuria]]. The mechanism of action is insulin independent.&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>